Protalix BioTherapeutics, Inc.
PLX
$1.98
$0.021.02%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 47.03% | -13.08% | 7.15% | -25.83% | -28.35% |
| Total Receivables | -37.13% | 179.06% | 557.18% | -6.75% | 24.37% |
| Inventory | 56.23% | 21.12% | 23.58% | 1.99% | -12.71% |
| Prepaid Expenses | -- | -21.20% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 16.98% | 630.00% | 38.29% | 1.34% | 95.81% |
| Total Current Assets | 42.70% | 10.98% | 38.97% | -15.36% | -19.75% |
|
|
|||||
| Total Current Assets | 42.70% | 10.98% | 38.97% | -15.36% | -19.75% |
| Net Property, Plant & Equipment | 30.11% | 25.53% | 21.77% | -5.76% | -6.66% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -11.49% | -6.75% | -5.53% | -15.02% | -8.85% |
| Total Assets | 38.49% | 12.16% | 33.63% | -14.26% | -17.74% |
|
|
|||||
| Total Accounts Payable | 3.98% | 16.02% | 71.45% | 64.59% | 30.99% |
| Total Accrued Expenses | 13.04% | 5.25% | -2.01% | -11.17% | 15.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.56% | -7.73% | -7.36% | -93.27% | -93.49% |
| Total Finance Division Other Current Liabilities | 24.47% | -7.57% | -54.09% | -78.02% | -76.94% |
| Total Other Current Liabilities | 24.47% | -7.57% | -54.09% | -78.02% | -76.94% |
| Total Current Liabilities | 12.61% | 3.50% | -9.39% | -58.44% | -55.64% |
|
|
|||||
| Total Current Liabilities | 12.61% | 3.50% | -9.39% | -58.44% | -55.64% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 84.94% | 72.31% | 62.36% | -9.46% | -15.29% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 21.78% | 18.25% | -13.56% | -12.77% | -22.61% |
| Total Liabilities | 22.39% | 12.94% | 0.79% | -54.60% | -52.22% |
|
|
|||||
| Common Stock & APIC | 1.57% | 2.76% | 3.61% | 3.61% | 2.77% |
| Retained Earnings | 4.01% | -1.75% | 1.40% | 1.62% | 1.01% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 48.71% | 11.62% | 63.11% | 74.60% | 51.78% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 48.71% | 11.62% | 63.11% | 74.60% | 51.78% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 48.71% | 11.62% | 63.11% | 74.60% | 51.78% |
|
|
|||||